TCRX smart money

Tscan Therapeutics, INC. (TCRX): 1 insider buy, 2 top funds holding it in the public filings.

Insider buys, 12 months$140k

Insider buys

FiledWhoRoleAmountPrice
2025-12-23Lynx1 Capital Management LPTenPercentOwner$140k$0.9

Top 100 funds holding it

#FundChangeWeightValue
9Bvf INC/Il0.06%$2M
71Baker Bros. Advisors LP0.00%$900k
Open the live smart money map